HALO logo
halo search icon
ALVIO
Valerio Therapeutics

ALVIO · Valerio Therapeutics

0.70

EUR
0.076 (12.18%)
24/07/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Euro311.66M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 24/07/2026 12:00:00 AM

Price Chart

Description

Valerio Therapeutics SA is a is a clinical-stage biotechnology company, which engages in the development of oncology drugs targeting tumor intracellular processes. The firm produces and develops orphan oncology products under the brand names Livatag, Validive, Beleodaq and AsiDNA. The company was founded by Jean Theron, Gilles Avenard, and Dominique Costantini on March 5, 1997 and is headquartered in Paris, France.

  • All-Companies
  • Big Candle
  • HALO All
  • HALO Price Momentum
  • HALO Small
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

-90.30%

EBITDA Margin

-4.50%

Operating Cashflow

€2m

Free Cash Flow Return

67.00%

ROIC

-178.40%

Interest Coverage

-0.30

Quick Ratio

0.80

Performance

52 weeks range

Low 0.05 - 0.98

Trade Value (12mth)

US$69,760.00

1 week

4.52%

1 month

212.63%

YTD

274.77%

1 year

845.45%

All time high

13.89

Additional Data

Shares Outstanding (Fully Diluted)

284m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

EUR

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Valerio Therapeutics (ALVIO:PAR)?
Halo FAQ
The current share price of Valerio Therapeutics (ALVIO:PAR) is EUR€0.70.
2
What is the 52-week high share price for Valerio Therapeutics (ALVIO:PAR)?
Halo FAQ
The 52-week high share price for Valerio Therapeutics (ALVIO:PAR) is EUR€0.98.
3
What is the 52-week low share price for Valerio Therapeutics (ALVIO:PAR)?
Halo FAQ
The 52-week low share price for Valerio Therapeutics (ALVIO:PAR) is EUR€0.05.
4
What is the dividend yield for Valerio Therapeutics (ALVIO:PAR)?
Halo FAQ
Valerio Therapeutics (ALVIO:PAR) does not pay a dividend.
5
What was Valerio Therapeutics (ALVIO:PAR) last dividend payment?
Halo FAQ
Valerio Therapeutics (ALVIO:PAR) does not pay a dividend.
6
What is the franking level for Valerio Therapeutics (ALVIO:PAR)?
Halo FAQ
Valerio Therapeutics (ALVIO:PAR) has a franking level of 0.00%.
7
In which sector is Valerio Therapeutics (ALVIO:PAR) classified?
Halo FAQ
Valerio Therapeutics (ALVIO:PAR) is classified in the Healthcare.